Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 trial evaluating long-term safety and efficacy of fixed-dose combination GSP 301 nasal spray for perennial allergic rhinitis has com…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients [Phase 3]
Phase 3 trial evaluating HL151 vs placebo in perennial allergic rhinitis has completed.
-
FDA approval · 2018-07-31FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original ANDA for montelukast sodium (generic montelukast).
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of acupuncture combined with moxibustion for perennial allergic rhinitis has been comp…
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for montelukast submitted by BluePoint Laboratories under ANDA 203366. The decision denotes appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of AGR Tablet for perennial allergic rhinitis in Korean patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Subcutaneous Immunotherapy for Mouse in Adults [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating subcutaneous immunotherapy using mouse allergen extract in adults with asthma or perennial allergi…
-
FDA approval · 2017-09-18FDA Approved: XHANCE — Original Application (OptiNose US, Inc.)
The FDA approved XHANCE, a new intranasal spray formulation of fluticasone propionate from OptiNose US, Inc., under an original NDA for trea…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis [Phase 3]
This document reports the completion of a Phase 3, placebo-controlled trial evaluating cetirizine for perennial allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
A completed head-to-head clinical trial comparing AVAMYS (mometasone furoate) with NASONEX (mometasone furoate) and Flixonase (fluticasone p…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine [Phase 1]
A Phase 1 study assessing the relative bioavailability of intranasal fluticasone furoate and levocabastine has been completed. The trial inv…
-
FDA approval · 2017-04-28FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Apotex Corp.)
FDA approves Apotex's original application for a generic nasal spray combining azelastine hydrochloride with fluticasone propionate for alle…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis [Phase 3]
A Phase 3 trial assessing the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Perennial Allergic Rhinitis Study In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial for perennial allergic rhinitis has completed.
-
FDA approval · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC.
-
FDA label_change · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) [Phase 3]
Phase 3 safety study evaluating the combination of ciclesonide nasal spray with inhaled fluticasone propionate/salmeterol in adults with per…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
Clinical trial update on the efficacy, safety, and tolerability of a 4-week regimen of ciclesonide nasal spray (200 mcg) for intermittent an…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) [Phase 3]
A Phase 3 trial evaluating the safety of three dose levels of ciclesonide nasal spray for perennial allergic rhinitis in pediatric patients …
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of ciclesonide nasal spray for perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) [Phase 3]
Phase 3 study evaluating potential additive inhibition of the HPA axis when ciclesonide nasal spray is used with orally inhaled beclomethaso…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) [Phase 3]
A Phase 3 study evaluated the safety and tolerability of ciclesonide nasal spray in children aged 2-5 with perennial allergic rhinitis; the …
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) [Phase 4]
Clinical trial update noting the completion of a Phase 4 study evaluating the combination of ciclesonide nasal spray and azelastine nasal sp…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). [Phase 3]
A Phase 3 study evaluating the efficacy and safety of a once-daily investigational nasal spray in adults and adolescents with perennial alle…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics [Phase 3]
Clinical trial update noting the completion of a Phase 3 study of GW685698X for perennial allergic rhinitis in pediatric patients.